J

Jeito Capital portfolio

Jeito Capital has 4 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It led 4 of the 5 rounds it joined. Its most recent investment on record is Bionyra's $165M Series A round in June 2026, which it led, alongside Sofinnova Partners, VIVES Funds, Sixty Degree Capital and 4 others. By category, its portfolio leans toward Health and bio (4) and AI agents (1). It has co-invested with Forbion Capital Partners, Sofinnova Partners and BioGeneration Ventures, most often Forbion Capital Partners (4 rounds).

What Jeito Capital invests in

• Health and bio · 4 · 100%
• AI agents · 1 · 25%

Jeito Capital recent investments

Company	Round	Date	Alongside
BBionyra	Series A · $165M · lead	Jun 22, 2026	Sofinnova Partners (lead), VIVES Funds, Sixty Degree Capital +4
AAzafaros	Series B+ · $150M · lead	May 13, 2025	Seroba Life Sciences, Schroders Capital, Pictet Alternative Advisors +2
CCatalYm	Series B+ · $150M	Jul 16, 2024	Vesalius Biocapital Partners, Omega Funds, Novartis Venture Fund +5
NNoema Pharma	Series B+ · $112M · lead	Mar 7, 2023	UPMC Enterprises, Sofinnova Partners, Polaris +3
CCatalYm	Series B+ · $50M · lead	Nov 22, 2022	Vesalius Biocapital Partners, Novartis Venture Fund, Forbion Capital Partners +4

How Jeito Capital invests

Share is of the 5 rounds on Recent Funding that name Jeito Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Jeito Capital portfolio companies

• BBionyra$165MSeries A · Jun 2026
• AAzafaros$150MSeries B+ · May 2025
• CCatalYm$150MSeries B+ · Jul 2024
• NNoema Pharma$112MSeries B+ · Mar 2023

Company	Round with Jeito Capital	Total raised	Latest raise
BBionyra Health and bio	Jun 22, 2026 Series A · $165M · lead	$165M	Jun 22, 2026 Series A
AAzafaros AI agents	May 13, 2025 Series B+ · $150M · lead	$177M	May 13, 2025 Series B+
CCatalYm Health and bio	Jul 16, 2024 Series B+ · $150M	$259.04M	Jul 16, 2024 Series B+
NNoema Pharma Health and bio	Mar 7, 2023 Series B+ · $112M · lead	$171M	Nov 4, 2025 Series B+

Most frequent co-investors

• FForbion Capital Partners4 shared rounds · last May 13, 2025
• SSofinnova Partners2 shared rounds · last Jun 22, 2026
• BBioGeneration Ventures2 shared rounds · last May 13, 2025
• BBrandon Capital2 shared rounds · last Jul 16, 2024
• VVesalius Biocapital Partners2 shared rounds · last Jul 16, 2024
• GGilde Healthcare2 shared rounds · last Jul 16, 2024
• NNovartis Venture Fund2 shared rounds · last Jul 16, 2024
• SSanofi Ventures1 shared round · last Jun 22, 2026
• AApollo Health Ventures1 shared round · last Jun 22, 2026
• SSixty Degree Capital1 shared round · last Jun 22, 2026
• VVIVES Funds1 shared round · last Jun 22, 2026
• LLMO1 shared round · last Jun 22, 2026

Similar investors

• BBain Capital Life Sciences4 companies · 3 deals in 12 mo
• DDecheng Capital4 companies · 3 deals in 12 mo
• DDuquesne Family Office4 companies · 3 deals in 12 mo
• QQatar Development Bank4 companies · 3 deals in 12 mo
• TThe Column Group4 companies · 3 deals in 12 mo
• AAdage Capital Management4 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Jeito Capital, which is a subset of its real portfolio. API: /api/v1/investors/jeito-capital (get a free API key). More: the most active VC firms and new venture capital funds.